Publikation: Tools for investigating ADP-ribosylation of specific PARP members
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
ADP-ribosylation is a post-translational modification that plays a critical role in several cellular processes, including DNA damage repair. It is catalyzed by the family of poly(ADP-ribose) polymerases (PARPs), by transferring single or multiple ADP-ribose molecules to proteins using nicotinamide adenine dinucleotide (NAD+) as a substrate. For a better understanding of their biological function, it is crucial to study the ADP-ribosylation of individual members of the PARP family. However, due to the overlapping functions of PARP members and the fact that they all use NAD+ as a substrate, this remains a challenge. Within this thesis novel approaches were developed to investigate ADP-ribosylation of individual PARP members. To this end, the “bump-hole strategy” was used, in which the nicotinamide binding site of a specific PARP member is modified by introducing a hydrophobic pocket (“hole”’) so that it can bind an orthogonal NAD+ containing a small alkyl or benzyl moiety (“bump”) on the nicotinamide moiety. In addition, a fluorescent or affinity tag was introduced directly onto the C2 position of the adenine moiety of the NAD+, allowing a direct read out of the ADP-ribosylation signal or enrichment of ADP-ribosylated proteins. To apply this strategy, it was first necessary to determine whether modifications at the C2 position of the adenine, such as the affinity tag d-desthiobiotin (DTB) are tolerated by the PARP enzymes. Therefore, the DTB labeled NAD+ analog DTB-NAD+ was used and its acceptance as a substrate of various PARP members was investigated in an auto-ADP ribosylation assay. Using this assay, it was shown that all PARPs tested (PARP1, 2, 3, 5a, 5b, 6, 10, and 14) accept DTB-NAD+ as a substrate. Based on this result orthogonal NAD+ analogs were synthesized that can no longer be used as a substrate by wild-type (wt)-PARPs and thus can be used in the bump-hole strategy together with a specific PARP-mutant. The nicotinamide site of the NAD+ analogs was modified with either a methyl (Me), ethyl (Et), or benzyl (Bn) group and the adenine moiety with a fluorophore 5’’-carboxy-tetramethyl rhodamine (TMR) or an affinity label DTB, resulting in the new NAD+ analogs Et-TMR-NAD+, Me-DTB-NAD+, Et-DTB-NAD+, and Bn-DTB-NAD+. These molecules were then evaluated in the bump-hole strategy for PARP1. For this purpose, the acceptance of all four NAD+s by the mutant KA-PARP1, which has a hydrophobic pocket (“hole”) in the nicotinamide binding site, was tested in vitro in auto-ADP ribosylation assays and compared with several wt-PARPs. Et-DTB-NAD+ showed the best results, since it was used as a substrate by KA-PARP1, but not or only to a very low extent by the tested wt-PARPs (PARP1, 2, 3, 5a, 5b). This new enzyme-substrate pair (KA-PARP1 and Et-DTB-NAD+) was then successfully used in affinity enrichment experiments in combination with LC-MS/MS proteomics. This led to the identification of 45 potential PARP1-specific protein targets. In the final section of this work, the method was extended to investigate ADP-ribosylation directly in living cells. To achieve this, the NAD+ analogs were transfected using the transfection reagent DOTAP. In addition to the KA-PARP1 and Et-DTB-NAD+ enzyme-substrate pair, the IG-PARP7 and Bn-DTB-NAD+ enzyme-substrate pair was employed. The attempt to ADP-ribosylate proteins using KA-PARP1 in cells was unsuccessful, likely due to its low activity. However, ADP-ribosylation of proteins was successful when using the PARP7 mutant IG-PARP7 together with its substrate Bn-DTB-NAD+. Thus, a novel enzyme-substrate pair was found potentially allowing the investigation of PARP7-specific ADP-ribosylation in cells.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
RIETH, Sonja, 2024. Tools for investigating ADP-ribosylation of specific PARP members [Dissertation]. Konstanz: Universität KonstanzBibTex
@phdthesis{Rieth2024Tools-70859, year={2024}, title={Tools for investigating ADP-ribosylation of specific PARP members}, author={Rieth, Sonja}, address={Konstanz}, school={Universität Konstanz} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/70859"> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/70859/4/Rieth_2-1uwiiuuqaz3f84.pdf"/> <dcterms:title>Tools for investigating ADP-ribosylation of specific PARP members</dcterms:title> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:creator>Rieth, Sonja</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:language>eng</dc:language> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/> <dc:contributor>Rieth, Sonja</dc:contributor> <dcterms:abstract>ADP-ribosylation is a post-translational modification that plays a critical role in several cellular processes, including DNA damage repair. It is catalyzed by the family of poly(ADP-ribose) polymerases (PARPs), by transferring single or multiple ADP-ribose molecules to proteins using nicotinamide adenine dinucleotide (NAD+) as a substrate. For a better understanding of their biological function, it is crucial to study the ADP-ribosylation of individual members of the PARP family. However, due to the overlapping functions of PARP members and the fact that they all use NAD+ as a substrate, this remains a challenge. Within this thesis novel approaches were developed to investigate ADP-ribosylation of individual PARP members. To this end, the “bump-hole strategy” was used, in which the nicotinamide binding site of a specific PARP member is modified by introducing a hydrophobic pocket (“hole”’) so that it can bind an orthogonal NAD+ containing a small alkyl or benzyl moiety (“bump”) on the nicotinamide moiety. In addition, a fluorescent or affinity tag was introduced directly onto the C2 position of the adenine moiety of the NAD+, allowing a direct read out of the ADP-ribosylation signal or enrichment of ADP-ribosylated proteins. To apply this strategy, it was first necessary to determine whether modifications at the C2 position of the adenine, such as the affinity tag d-desthiobiotin (DTB) are tolerated by the PARP enzymes. Therefore, the DTB labeled NAD+ analog DTB-NAD+ was used and its acceptance as a substrate of various PARP members was investigated in an auto-ADP ribosylation assay. Using this assay, it was shown that all PARPs tested (PARP1, 2, 3, 5a, 5b, 6, 10, and 14) accept DTB-NAD+ as a substrate. Based on this result orthogonal NAD+ analogs were synthesized that can no longer be used as a substrate by wild-type (wt)-PARPs and thus can be used in the bump-hole strategy together with a specific PARP-mutant. The nicotinamide site of the NAD+ analogs was modified with either a methyl (Me), ethyl (Et), or benzyl (Bn) group and the adenine moiety with a fluorophore 5’’-carboxy-tetramethyl rhodamine (TMR) or an affinity label DTB, resulting in the new NAD+ analogs Et-TMR-NAD+, Me-DTB-NAD+, Et-DTB-NAD+, and Bn-DTB-NAD+. These molecules were then evaluated in the bump-hole strategy for PARP1. For this purpose, the acceptance of all four NAD+s by the mutant KA-PARP1, which has a hydrophobic pocket (“hole”) in the nicotinamide binding site, was tested in vitro in auto-ADP ribosylation assays and compared with several wt-PARPs. Et-DTB-NAD+ showed the best results, since it was used as a substrate by KA-PARP1, but not or only to a very low extent by the tested wt-PARPs (PARP1, 2, 3, 5a, 5b). This new enzyme-substrate pair (KA-PARP1 and Et-DTB-NAD+) was then successfully used in affinity enrichment experiments in combination with LC-MS/MS proteomics. This led to the identification of 45 potential PARP1-specific protein targets. In the final section of this work, the method was extended to investigate ADP-ribosylation directly in living cells. To achieve this, the NAD+ analogs were transfected using the transfection reagent DOTAP. In addition to the KA-PARP1 and Et-DTB-NAD+ enzyme-substrate pair, the IG-PARP7 and Bn-DTB-NAD+ enzyme-substrate pair was employed. The attempt to ADP-ribosylate proteins using KA-PARP1 in cells was unsuccessful, likely due to its low activity. However, ADP-ribosylation of proteins was successful when using the PARP7 mutant IG-PARP7 together with its substrate Bn-DTB-NAD+. Thus, a novel enzyme-substrate pair was found potentially allowing the investigation of PARP7-specific ADP-ribosylation in cells.</dcterms:abstract> <dc:rights>terms-of-use</dc:rights> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/70859"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/70859/4/Rieth_2-1uwiiuuqaz3f84.pdf"/> <dcterms:issued>2024</dcterms:issued> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2024-09-30T06:00:57Z</dc:date> </rdf:Description> </rdf:RDF>